Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management

被引：57

作者：

Jadoul, Michel ^{[1
]}

Berenguer, Marina C. ^{[2
,3
,4
,5
]}

Doss, Wahid ^{[6
]}

Fabrizi, Fabrizio ^{[7
]}

Izopet, Jacques ^{[8
,9
]}

Jha, Vivekanand ^{[10
,11
]}

Kamar, Nassim ^{[12
,13
,14
,15
]}

Kasiske, Bertram L. ^{[16
,17
]}

Lai, Ching-Lung ^{[18
,19
]}

Morales, Jose M. ^{[20
]}

Patel, Priti R. ^{[21
]}

Po, Stanislas ^{[22
]}

Silva, Marcelo O. ^{[23
,24
]}

Balk, Ethan M. ^{[25
]}

Gordon, Craig E. ^{[26
]}

Earley, Amy ^{[27
]}

Di, Mengyang ^{[25
,28
]}

Martin, Paul ^{[29
]}

机构：

[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, Brussels, Belgium

[2] Hosp Univ & Politecn La Fe, Dept Gastroenterol, Hepatol Unit, Valencia, Spain

[3] Hosp Univ & Politecn La Fe, Inst Invest La Fe, Valencia, Spain

[4] CIBERehd, Valencia, Spain

[5] Univ Valencia, Sch Med, Valencia, Spain

[6] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt

[7] Maggiore Hosp & IRCCS Fdn, Div Nephrol, Milan, Italy

[8] Toulouse Univ Hosp, Dept Virol, Hepatitis E Virus Natl Reference Ctr, Toulouse, France

[9] Toulouse Univ Paul Sabatier, Toulouse Purpan Ctr Pathophysiol, INSERM, UMR 1043,CNRS,UMR 5282,CPTP, Toulouse, France

[10] George Inst Global Hlth, New Delhi, India

[11] Univ Oxford, Oxford, England

[12] CHU Rangueil, Dept Nephrol, Toulouse, France

[13] CHU Rangueil, Dept Organ Transplantat, Toulouse, France

[14] CHU Purpan, INSERM, U1043, IFR BMT, Toulouse, France

[15] Univ Paul Sabatier, Toulouse, France

[16] Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA

[17] Minneapolis Med Res Fdn Inc, Sci Registry Transplant Recipients, Minneapolis, MN USA

[18] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China

[19] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China

[20] Hosp 12 Octubre, Res Inst, Nephrol Dept, Madrid, Spain

[21] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA

[22] Univ Paris 05, Hop Cochin, Hepatol Dept, INSERM,U1223,Inst Pasteur, Paris, France

[23] Hosp Univ Austral, Hepatol & Liver Transplant Unit, Buenos Aires, DF, Argentina

[24] LALREAN, Buenos Aires, DF, Argentina

[25] Brown Univ, Sch Publ Hlth, Ctr Evidence Synth Hlth, Providence, RI 02912 USA

[26] Boston Univ, Med Ctr, Renal Sect, Boston, MA USA

[27] Evidera, Waltham, MA USA

[28] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Providence, RI 02903 USA

[29] Univ Miami, Div Hepatol, Miami, FL USA

来源：

KIDNEY INTERNATIONAL | 2018年 / 94卷 / 04期

关键词：

antivirals; chronic kidney disease; cryoglobulinemia; dialysis; direct-acting antivirals; glomerular diseases; guideline; hemodialysis; hepatitis C virus; infection control; KDIGO; kidney transplantation; liver testing; nosocomial transmission; screening; systematic review;

D O I：

10.1016/j.kint.2018.06.011

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy and in those with a kidney transplant. Since the publication of the original Kidney Disease: Improving Global Outcomes (KDIGO) HCV Guideline in 2008, major advances in HCV management, particularly with the advent of direct-acting antiviral therapies, have now made the cure of HCV possible in CKD patients. In addition, diagnostic techniques have evolved to enable the noninvasive diagnosis of liver fibrosis. Therefore, the Work Group undertook a comprehensive review and update of the KDIGO HCV in CKD Guideline. This Executive Summary highlights key aspects of the guideline recommendations.

引用

页码：663 / 673

页数：11

共 50 条

[21] KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE EVALUATION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE
Stevens, Paul E.
Ahmed, Sofia B.
Carrero, Juan Jesus
Foster, Bethany
Francis, Anna
Hall, Rasheeda K.
Herrington, Will G.
Hill, Guy
Inker, Lesley A.
Kazancio, Rumeyza
Lamb, Edmund
Lin, Peter
Levin, Adeera
KIDNEY INTERNATIONAL, 2024, 105 (04) : S117 - S117
[22] Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward
Levin, Adeera
Stevens, Paul E.
KIDNEY INTERNATIONAL, 2014, 85 (01) : 49 - 61
[23] KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD
Taler, Sandra J.
Agarwal, Rajiv
Bakris, George L.
Flynn, Joseph T.
Nilsson, Peter M.
Rahman, Mahboob
Sanders, Paul W.
Textor, Stephen C.
Weir, Matthew R.
Townsend, Raymond R.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (02) : 201 - 213
[24] Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters
Ketteler, Markus
Block, Geoffrey A.
Evenepoel, Pieter
Fukagawa, Masafumi
Herzog, Charles A.
McCann, Linda
Moe, Sharon M.
Shroff, Rukshana
Tonelli, Marcello A.
Toussaint, Nigel D.
Vervloet, Marc G.
Leonard, Mary B.
KIDNEY INTERNATIONAL, 2017, 92 (01) : 26 - 36
[25] Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia
Tomas, Salek
Bedrich, Friedecky
Josef, Kratochvila
Kveta, Pelinkova
Marek, Budina
BIOCHEMIA MEDICA, 2019, 29 (03)
[26] Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD
Mann, Johannes F. E.
Chang, Tara I.
Cushman, William C.
Furth, Susan L.
Ix, Joachim H.
Hou, Fan Fan
Knoll, Gregory A.
Muntner, Paul
Pecoits-Filho, Roberto
Sarnak, Mark J.
Tomson, Charles R. V.
Craig, Jonathan C.
Tunnicliffe, David J.
Howell, Martin
Tonelli, Marcello
Cheung, Michael
Earley, Amy
Cheung, Alfred K.
CURRENT CARDIOLOGY REPORTS, 2021, 23 (09)
[27] Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD
Johannes F. E. Mann
Tara I. Chang
William C. Cushman
Susan L. Furth
Joachim H. Ix
Fan Fan Hou
Gregory A. Knoll
Paul Muntner
Roberto Pecoits-Filho
Mark J. Sarnak
Charles R. V. Tomson
Jonathan C. Craig
David J. Tunnicliffe
Martin Howell
Marcello Tonelli
Michael Cheung
Amy Earley
Alfred K. Cheung
Current Cardiology Reports, 2021, 23
[28] Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline
Awan, Ahmed A.
Jadoul, Michel
Martin, Paul
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) : 2158 - 2167
[29] KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD
Sarnak, Mark J.
Bloom, Roy
Muntner, Paul
Rahman, Mahboob
Saland, Jeffrey M.
Wilson, Peter W. F.
Fried, Linda
AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (03) : 354 - 366
[30] Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale
Ratcliffe, Laura E. K.
Thomas, Wayne
Glen, Jessica
Padhi, Smita
Pordes, Ben A. J.
Wonderling, David
Connell, Roy
Stephens, Suzanne
Mikhail, Ashraf I.
Fogarty, Damian G.
Cooper, Jan K.
Dring, Belinda
Devonald, Mark A. J.
Brown, Chris
Thomas, Mark E.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (04) : 548 - 558

← 1 2 3 4 5 →